Will pharma finally score a policy win for 340B?
PharmaVoice
JUNE 16, 2025
The industry is awaiting guidance on a rebate approach to the contentious drug discount program for hospitals and aiming for tighter oversight. Aimed at providing discounted drugs to hospitals in lower income areas, pharma leaders argue the program is vulnerable to abuse and sometimes boosts hospital profits without helping patients.
Let's personalize your content